LBA6 EV-302/KEYNOTE-A39: Open-label, randomized phase III study of enfortumab vedotin in combination with pembrolizumab (EV+P) vs chemotherapy (Chemo) in previously untreated locally advanced metastatic urothelial carcinoma (la/mUC)

• DOI: 10.1016/j.annonc.2023.10.106
• Publication Date: 2023-10-20T13:23:33Z
• Authors: T.B. Powles; B. Perez Valderrama; S. Gupta; J. Bedke; E. Kikuchi; J. Hoffman-Censits; G. Iyer; C. Vulsteke; S.H. Park; S.J. Shin; D.E. Castellano G...; G. Fornarini; J-R. Li; M. Gumus; N. Mar; S. Narayanan; X. Yu; S. Gorla; B.M.S. Homet More...
• Keywords: Carboplatin; Metastatic Urothelial Carcinoma; Open label